Germany
Japan
United Kingdom
China
Antibodies
View as table Download
Goat Polyclonal Anti-HIF1a Antibody
| Applications | WB |
| Reactivities | Canine, Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | Purified recombinant peptide derived from within residues 780 aa to the C-terminus of human HIF1a produced in E. coli. |
Rabbit polyclonal IRF-3 (Ser385) antibody(Phospho-specific)
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human IRF-3 around the phosphorylation site of serine 385 (G-A-SP-S-L). |
| Modifications | Phospho-specific |
Rabbit anti-STAT3 (Phospho-Tyr705) polyclonal antibody (Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from humanSTAT3 around the phosphorylation site of tyrosine 705 (A-P-YP-L-K). |
| Modifications | Phospho-specific |
Rabbit polyclonal Neuro D (Ser274) antibody(Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human Neuro D around the phosphorylation site of serine 274 (P-L-SP-P-P). |
| Modifications | Phospho-specific |
Rabbit polyclonal GR (Ab-211) antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human GR around the phosphorylation site of serine 211 (N-E-S-P-W). |
Rabbit polyclonal MITF (Ab-180/73) antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human MITF around the phosphorylation site of serine 180/73 (P-N-SP-P-M). |
Rabbit Polyclonal CrkII (Tyr221) Antibody (Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human CrkII around the phosphorylation site of Tyrosine 221 |
| Modifications | Phospho-specific |
Rabbit polyclonal anti-NR1I2 antibody
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized peptide derived from internal of human NR1I2. |
Rabbit polyclonal Catenin-beta (Tyr489) antibody(Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human Catenin-β around the phosphorylation site of tyrosine 489 (L-H-YP-G-L). |
| Modifications | Phospho-specific |
Goat Polyclonal Anti-HIF1a Antibody
| Applications | WB |
| Reactivities | Canine, Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | Purified recombinant peptide derived from within residues 470 to 590 aa of human HIF1a produced in E. coli. |
USD 345.00
In Stock
Rabbit polyclonal anti-KAP0 antibody
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized peptide derived from N-terminal of human KAP0. |
Rabbit polyclonal anti-HOXC6 antibody
| Applications | WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized peptide derived from C-terminal of human HOXC6. |
Rabbit Polyclonal STAT5A (Ser780) Antibody (Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human STAT5A around the phosphorylation site of Serine 780 |
| Modifications | Phospho-specific |
Rabbit Polyclonal STAT5A/B (Ser725/730) Antibody (Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human STAT5A/B around the phosphorylation site of Serine 725/730 |
| Modifications | Phospho-specific |
Anti-SOX2 Rabbit Polyclonal Antibody
| Applications | ELISA, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Fusion protein corresponding to C terminal 250 amino acids of human SRY (sex determining region Y)-box 2 |
Rabbit Polyclonal Anti-MYCN Antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide of human MYCN |
USD 379.00
In Stock
Active filters
Reactivities
- Human
Applications
- WB
Conjugates
- Unconjugated
Families
- Transcription Factors
Citations
- Yes
Availabilities
- In Stock
Filter by
Category
Target Symbol
- CTNNB1 (5)
- NR4A3 (4)
- PRRX1 (4)
- SOX17 (4)
- TP53 (4)
- ARNTL (3)
- GATA4 (3)
- KEAP1 (3)
- PARP1 (3)
- PRKAR1A (3)
- SNAI2 (3)
- ZEB1 (3)
- ZEB2 (3)
- ARNT (2)
- CDX2 (2)
- CRABP2 (2)
- EGR2 (2)
- ETS2 (2)
- FOSL1 (2)
- HDAC6 (2)
- HIF1A (2)
- MDM4 (2)
- PDX1 (2)
- PGR (2)
- POU5F1 (2)
- REL (2)
- RELA (2)
- SIRT6 (2)
- SQSTM1 (2)
- STAT3 (2)
- STAT5A (2)
- TGFB1 (2)
- BRCA1 (1)
- CCNE1 (1)
- CRK (1)
- CUX1 (1)
- DNMT1 (1)
- EPAS1 (1)
- ESR1 (1)
- EZH2 (1)
- FOXP1 (1)
- FOXP3 (1)
- FOXQ1 (1)
- GAS7 (1)
- GLI1 (1)
- HHEX (1)
- HIF3A (1)
- HOXC6 (1)
- HOXC8 (1)
- HOXD10 (1)
- IRF3 (1)
- MDM2 (1)
- MITF (1)
- MYCN (1)
- NDN (1)
- NEUROD1 (1)
- NONO (1)
- NR1I2 (1)
- NR3C1 (1)
- PAX5 (1)
- POFUT1 (1)
- PPARGC1A (1)
- SATB1 (1)
- SEC14L2 (1)
- SMURF2 (1)
- SOD2 (1)
- SOX2 (1)
- SOX9 (1)
- SSB (1)
- TLE1 (1)
- TNF (1)
- TP63 (1)
- TWIST2 (1)
- VHL (1)
- WWTR1 (1)
Antibody Hosts
Clonalities
Knockout (KO) Validation
Modifications
Pathways
- Pathways in cancer (28)
- Wnt signaling pathway (15)
- Prostate cancer (13)
- Chronic myeloid leukemia (12)
- Colorectal cancer (11)
- Apoptosis (10)
- Basal cell carcinoma (10)
- MAPK signaling pathway (10)
- Pancreatic cancer (10)
- Endometrial cancer (9)
- Renal cell carcinoma (9)
- Thyroid cancer (9)
- Adherens junction (8)
- Cell cycle (8)
- p53 signaling pathway (8)
- Neurotrophin signaling pathway (7)
- Small cell lung cancer (7)
- Ubiquitin mediated proteolysis (7)
- Acute myeloid leukemia (6)
- Adipocytokine signaling pathway (6)
- Focal adhesion (6)
- Huntington's disease (6)
- Melanogenesis (6)
- Melanoma (6)
- Amyotrophic lateral sclerosis (ALS) (5)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (5)
- Bladder cancer (5)
- Chemokine signaling pathway (5)
- Glioma (5)
- Insulin signaling pathway (5)
- Leukocyte transendothelial migration (5)
- Pathogenic Escherichia coli infection (5)
- Tight junction (5)
- Jak-STAT signaling pathway (4)
- Maturity onset diabetes of the young (4)
- Non-small cell lung cancer (4)
- RIG-I-like receptor signaling pathway (4)
- TGF-beta signaling pathway (4)
- Toll-like receptor signaling pathway (4)
- Base excision repair (3)
- Circadian rhythm - mammal (3)
- Cytokine-cytokine receptor interaction (3)
- Cytosolic DNA-sensing pathway (3)
- Dilated cardiomyopathy (3)
- ErbB signaling pathway (3)
- Hypertrophic cardiomyopathy (HCM) (3)
- NOD-like receptor signaling pathway (3)
- Oocyte meiosis (3)
- T cell receptor signaling pathway (3)
- Type II diabetes mellitus (3)
- Allograft rejection (2)
- B cell receptor signaling pathway (2)
- Dorso-ventral axis formation (2)
- Endocytosis (2)
- Epithelial cell signaling in Helicobacter pylori infection (2)
- Graft-versus-host disease (2)
- Progesterone-mediated oocyte maturation (2)
- Systemic lupus erythematosus (2)
- Type I diabetes mellitus (2)
- mTOR signaling pathway (2)
- Alzheimer's disease (1)
- Antigen processing and presentation (1)
- Asthma (1)
- Autoimmune thyroid disease (1)
- Cell adhesion molecules (CAMs) (1)
- Cysteine and methionine metabolism (1)
- Fc epsilon RI signaling pathway (1)
- Fc gamma R-mediated phagocytosis (1)
- Hedgehog signaling pathway (1)
- Hematopoietic cell lineage (1)
- Metabolic pathways (1)
- Natural killer cell mediated cytotoxicity (1)
- Neuroactive ligand-receptor interaction (1)
- Regulation of actin cytoskeleton (1)
- Viral myocarditis (1)